Immunological responses to a 39.8 kDa Plasmodium vivax tryptophan-rich antigen (PvTRAg39.8) among humans

Microbes and Infection

Volumn 10, Issue 10-11, 2008, Pages 1097-1105

  Garg, Sheena ^a   Chauhan, Shyam S ^a   Singh, Neeru ^b   Sharma, Yagya D ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

Cytokines; Humoral and cellular immune response; Malaria vaccine; Plasmodium vivax; Tryptophan rich antigen

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; NUCLEOTIDE; PVTRAG39.8 ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CODON; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; ESCHERICHIA COLI; GENE MAPPING; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MALARIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM VIVAX; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZONT; TRANSCRIPTION INITIATION SITE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHROMOSOME MAPPING; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALARIA, VIVAX; PLASMODIUM VIVAX; RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; SEQUENCE ANALYSIS, PROTEIN; TRYPTOPHAN;

MURINAE; PLASMODIUM VIVAX;

EID: 54049143800     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.05.008     Document Type: Article

References (37)

1. Mendis K., Sina B.J., Marchesini P., and Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64 (2001) 97-106
2. Zakeri S., Abouie Mehrizi A., Djadid N.D., and Snounou G. Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran. Trop. Med. Int. Health 11 (2006) 729-737
3. Bueno L.L., Fujiwara R.T., Soares I.S., and Braga E.M. Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and MSP-119 on the innate immune response. Vaccine 26 (2008) 1204-1213
4. Tran T.M., Oliveira-Ferreira J., Moreno A., Santos F., Yazdani S.S., Chitnis C.E., Altman J.D., Meyer E.V., Barnwell J.W., and Galinski M.R. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. Am. J. Trop. Med. Hyg. 73 (2005) 244-255
5. Wickramarachchi T., Illeperuma R.J., Perera L., Bandara S., Holm I., Longacre S., Handunnetti S.M., and Udagama-Randeniya P.V. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka. Int. J. Parasitol. 37 (2007) 199-208
6. Xainli J., Baisor M., Kastens W., Bockarie M., Adams J.H., and King C.L. Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans. J. Immunol. 169 (2002) 3200-3207
7. Arevalo-Herrera M., Solarte Y., Yasnot M.F., Castellanos A., Rincon A., Saul A., Mu J., Long C., Miller L., and Herrera S. Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant protein. Am. J. Trop. Med. Hyg. 73 (2005) 32-37
8. Caro-Aguilar I., Rodriguez A., Calvo-Calle J.M., Guzman F., De la Vega P., Patarroyo M.E., Galinski M.R., and Moreno A. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens. Infect. Immun. 70 (2002) 3479-3492
9. Burns Jr. J.M., Adeeku E.K., and Dunn P.D. Protective immunization with a novel membrane protein of Plasmodium yoelii-infected erythrocytes. Infect. Immun. 67 (1999) 675-680
10. Uhlemann A.C., Oguariri R.M., McColl D.J., Coppel R.L., Kremsner P.G., Anders R.F., and Kun J.F. Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii. Mol. Biochem. Parasitol. 118 (2001) 41-48
11. Ntumngia F.B., Bouyou-Akotet M.K., Uhlemann A.C., Mordmuller B., Kremsner P.G., and Kun J.F. Characterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites. Mol. Biochem. Parasitol. 137 (2004) 349-353
12. Ntumngia F.B., Bahamontes-Rosa N., and Kun J.F. Genes coding for tryptophan-rich proteins are transcribed throughout the asexual cycle of Plasmodium falciparum. Parasitol. Res. 96 (2005) 347-353
13. Jalah R., Sarin R., Sud N., Alam M.T., Parikh N., Das T.K., and Sharma Y.D. Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax. Mol. Biochem. Parasitol. 142 (2005) 158-169
14. Siddiqui A.A., Bora H., Singh N., Dash A.P., and Sharma Y.D. Expression, purification and characterization of the immunological response to a 40 kDa Plasmodium vivax tryptophan-rich antigen (PvTRAg40). Infect. Immun. 76 (2008) 2576-2586
15. Siddiqui A.A., Singh N., and Sharma Y.D. Expression and purification of a Plasmodium vivax antigen - PvTARAg55 tryptophan - and alanine-rich antigen and its immunological responses in human subjects. Vaccine 26 (2007) 96-107
16. Seth P., Mahajan V.S., and Chauhan S.S. Transcription of human cathepsin L mRNA species hCATL B from a novel alternative promoter in the first intron of its gene. Gene 321 (2003) 83-91
17. Vinayak S., Mittra P., and Sharma Y.D. Wide variation in microsatellite sequences within each Pfcrt mutant haplotype. Mol. Biochem. Parasitol. 147 (2006) 101-108
18. Siddiqui A.A., Jalah R., and Sharma Y.D. Expression and purification of HtpX-like small heat shock integral membrane protease of an unknown organism related to Methylobacillus flagellatus. J. Biochem. Biophys. Methods 70 (2007) 539-546
19. Ray P., Ansari M.A., and Sharma Y.D. Plasmodium vivax: immune responses in a cross-section of the population in the Delhi area of India. Am. J. Trop. Med. Hyg. 51 (1994) 436-443
20. Hviid L., Theander T.G., Abu-Zeid Y.A., Abdulhadi N.H., Jakobsen P.H., Saeed B.O., Jepsen S., Bayoumi R.A., and Jensen J.B. Loss of cellular immune reactivity during acute Plasmodium falciparum malaria. FEMS Microbiol. Immunol. 3 (1991) 219-227
21. Riley E.M., Andersson G., Otoo L.N., Jepsen S., and Greenwood B.M. Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. Clin. Exp. Immunol. 73 (1988) 17-22
22. Swain S.L., Bradley L.M., Croft M., Tonkonogy S., Atkins G., Weinberg A.D., Duncan D.D., Hedrick S.M., Dutton R.W., and Huston G. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123 (1991) 115-144
23. Giron-Gonzalez J.A., Moral F.J., Elvira J., Garcia-Gil D., Guerrero F., Gavilan I., and Escobar L. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur. J. Endocrinol. 143 (2000) 31-36
24. Burns J.M., Adeeku E.K., Belk C.C., and Dunn P.D. An unusual tryptophan-rich domain characterizes two secreted antigens of Plasmodium yoelii-infected erythrocytes. Mol. Biochem. Parasitol. 110 (2000) 11-21
25. Shi Y.P., Hasnain S.E., Sacci J.B., Holloway B.P., Fujioka H., Kumar N., Wohlhueter R., Hoffman S.L., Collins W.E., and Lal A.A. Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc. Natl. Acad. Sci. USA 96 (1999) 1615-1620
26. Tebo A.E., Kremsner P.G., and Luty A.J. Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Exp. Parasitol. 98 (2001) 20-28
27. Conway D.J., Cavanagh D.R., Tanabe K., Roper C., Mikes Z.S., Sakihama N., Bojang K.A., Oduola A.M., Kremsner P.G., Arnot D.E., Greenwood B.M., and McBride J.S. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat. Med. 6 (2000) 689-692
28. Metzger W.G., Okenu D.M., Cavanagh D.R., Robinson J.V., Bojang K.A., Weiss H.A., McBride J.S., Greenwood B.M., and Conway D.J. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol 25 (2003) 307-312
29. Polley S.D., Mwangi T., Kocken C.H., Thomas A.W., Dutta S., Lanar D.E., Remarque E., Ross A., Williams T.N., Mwambingu G., Lowe B., Conway D.J., and Marsh K. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23 (2004) 718-728
30. Nardin E.H., and Nussenzweig R.S. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11 (1993) 687-727
31. Burns Jr. J.M., Dunn P.D., and Russo D.M. Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens. Infect. Immun. 65 (1997) 3138-3145
32. Stevenson M.M., and Tam M.F. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin. Exp. Immunol. 92 (1993) 77-83
33. Taylor-Robinson A.W., and Phillips R.S. B cells are required for the switch from Th1- to Th2-regulated immune responses to Plasmodium chabaudi chabaudi infection. Infect. Immun. 62 (1994) 2490-2498
34. Rhee M.S., Akanmori B.D., Waterfall M., and Riley E.M. Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria. Clin. Exp. Immunol. 126 (2001) 503-510
35. Elghazali G., Perlmann H., Rutta A.S., Perlmann P., and Troye-Blomberg M. Elevated plasma levels of IgE in Plasmodium falciparum-primed individuals reflect an increased ratio of IL-4 to interferon-gamma (IFN-gamma)-producing cells. Clin. Exp. Immunol. 109 (1997) 84-89
36. Metzger D.W., McNutt R.M., Collins J.T., Buchanan J.M., Van Cleave V.H., and Dunnick W.A. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms. Eur. J. Immunol. 27 (1997) 1958-1965
37. Schofield L., and Mueller I. Clinical immunity to malaria. Curr. Mol. Med. 6 (2006) 205-221